Prognostic Nomogram and Predictive Factors in Refractory or Relapsed Diffuse Large B-Cell Lymphoma Patients Failing Front-Line R-CHOP Regimens

Background: The clinical course of relapsed or refractory (r/r) diffuse large B-cell lymphoma (DLBCL) is variable, with limited efficacy data of second-line treatment in a post-rituximab real-world context. Hence, we explored the predictors and constructed a nomogram for risk stratification in this...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Cancer
Autors principals: Jiang, Shiyu, Qin, Yan, Liu, Peng, Yang, Jianliang, Yang, Sheng, He, Xiaohui, Zhou, Shengyu, Gui, Lin, Zhang, Changgong, Zhou, Liqiang, Sun, Yan, Shi, Yuankai
Format: Artigo
Idioma:Inglês
Publicat: Ivyspring International Publisher 2020
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6995391/
https://ncbi.nlm.nih.gov/pubmed/32047558
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.36997
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars